CN105054007A - Health-care moringa seed product - Google Patents
Health-care moringa seed product Download PDFInfo
- Publication number
- CN105054007A CN105054007A CN201510435212.7A CN201510435212A CN105054007A CN 105054007 A CN105054007 A CN 105054007A CN 201510435212 A CN201510435212 A CN 201510435212A CN 105054007 A CN105054007 A CN 105054007A
- Authority
- CN
- China
- Prior art keywords
- moringa seeds
- parts
- health products
- matrimony vine
- stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000220215 Moringa Species 0.000 title claims abstract description 68
- 235000011347 Moringa oleifera Nutrition 0.000 title claims abstract description 68
- 244000241838 Lycium barbarum Species 0.000 claims description 34
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 34
- 240000004638 Dendrobium nobile Species 0.000 claims description 29
- 238000002156 mixing Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 3
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 3
- 229940029339 inulin Drugs 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 241001523681 Dendrobium Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 28
- 241000699666 Mus <mouse, genus> Species 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 210000001744 T-lymphocyte Anatomy 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000294142 Vascellum Species 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 235000021552 granulated sugar Nutrition 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000004218 vascular function Effects 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108700031361 Brachyury Proteins 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a health-care product, in particular to a health-care moringa seed product. The health-care moringa seed product is characterized by consisting of the following ingredients in parts by weight: 20-60 parts of moringa seeds, 5-25 parts of black Chinese wolfberries, and 2-20 parts of dendrobium. The composition is complementary, and has the synergy effects of preventing diseases, improving immunity, delaying the senescence of human bodies, and resisting tumors.
Description
Technical field
The present invention relates to a kind of health products, particularly relate to a kind of moringa seeds health products.
Background technology
Moringa seeds, Moringa originates in India.According to domestic and international clinical report, often edible moringa seeds can develop immunitypty, toxin expelling, body shaping, anti-aging, anticancer and have multiple chronic and major disease and improve effect greatly.Moringa seeds is natural green food, and the complete nutrients matter containing needed by human body, it can replace B B-complex, calcium tablet, cod-liver oil etc.Good effect is had especially to hypertension, high fat of blood, diabetes, gout etc.Moringa seeds can assist to improve, prevent disease, improving water flood, strengthens memory, delays senility, and also can be used to the disease for the treatment of the privileged sites such as liver, spleen, channels and collaterals.It also has the effects such as treating halitosis and sobers up.
Black matrimony vine, be the perennial shrub of Lycium section, black matrimony vine contains 17 seed amino acids, 13 kinds of trace elements, and wherein the content of calcium, magnesium, copper, zinc, iron is also higher than red matrimony vine.It is the most effective natural free radical scavenger that wild black matrimony vine contains a large amount of anthocyanin elements, and delaying human body cell tissue is old and feeble.Keep younger state, promote longevity.It is medicinal, and health value is far away higher than common red matrimony vine.Be described as " soft gold ".Drink with wild black matrimony vine bubble for a long time, tool obviously protects vision protection effect, prevents and treats diabetes effect preferably in addition.There is obvious antifatigue, protect the liver, antitumor, dredging vascellum, step-down, protection Cardiovascular System.
The stem of noble dendrobium, medicinal history is long, and medicinal ingredient is not only abundant but also balanced, can treat multiple illness, is used for clinically treating chronic pharyngitis, gastrointestinal disease, ophthalmology disease, the treatment of thrombosis, diabetes, arthritis, cancer or supplemental treatment.Particularly in recent years for eliminating the side effect after cancer radiation, chemotherapy and recovering physical efficiency, effect is fairly obvious.Anti-ageing, improve immunity, promoting blood circulation and removing blood stasis, improve cardio and vascular function, antitumor, treatment disease of digestive system, treatment ophthalmology disease.
Current above-mentioned various raw material all has folk prescription or the finished product processed with other raw material compound or patent, and formulation has tablet, but has no the product and reported in literature that are made up of above three kinds of raw materials.
Summary of the invention
The object of this invention is to provide a kind of moringa seeds health products, it is characterized in that, be mainly grouped into by the one-tenth of following weight portion: moringa seeds 20-60 part, black matrimony vine 5-25 part, stem of noble dendrobium 2-20 part are obtained by mixing.
Further, be grouped into by the one-tenth of following weight portion: moringa seeds 30-50 part, black matrimony vine 8-22 part, stem of noble dendrobium 5-16 part are obtained by mixing.
Further, also comprise probio, account for 60-90 part by weight.
Further, also comprise probio, account for 70-80 part by weight.
Further, described composition also comprises inulin, starch, xylo-oligosaccharide or cellulose.
Further, described composition may be used for preparing electuary, capsule, oral liquid or tablet.
Composition of the present invention is that the functional characteristics respectively had according to moringa seeds, black matrimony vine, the stem of noble dendrobium carries out matched combined, moringa seeds can develop immunitypty, toxin expelling, body shaping, the effect such as anti-aging, anticancer; Black matrimony vine has delaying human body cell ageing, has obvious antifatigue, protects the liver, antitumor, dredging vascellum, step-down, protection Cardiovascular System; And the stem of noble dendrobium has anti-ageing, improve immunity, promoting blood circulation and removing blood stasis, improve cardio and vascular function, antitumor; Three supplements and complements each other, and for prevent disease, improves immunity, delaying human body caducity, antitumorly has synergy.
Detailed description of the invention
Technical scheme of the present invention is described in detail below in conjunction with embodiment.
Embodiment 1:
A kind of moringa seeds health products, comprise moringa seeds, black matrimony vine, the stem of noble dendrobium, the weight of various component: moringa seeds 60 parts, black matrimony vine 5 parts, the stem of noble dendrobium 20 parts are obtained by mixing.Black matrimony vine, moringa seeds, the stem of noble dendrobium can be all crude drug or the composition for extract.Described extract extracts by the method for prior art with crude drug and obtains.
Embodiment 2:
A kind of moringa seeds health products, comprise moringa seeds, black matrimony vine, the stem of noble dendrobium, the weight of various component: moringa seeds 20 parts, black matrimony vine 25 parts, the stem of noble dendrobium 2 parts are obtained by mixing.All the other conditions are identical with embodiment 1.
Embodiment 3:
A kind of moringa seeds health products, comprise moringa seeds, black matrimony vine, the stem of noble dendrobium, the weight of various component: moringa seeds 30 parts, black matrimony vine 22 parts, the stem of noble dendrobium 5 parts.All the other conditions are identical with embodiment 1.
Embodiment 4:
A kind of moringa seeds health products, comprise moringa seeds, black matrimony vine, the stem of noble dendrobium, the weight of various component: moringa seeds 50 parts, black matrimony vine 8 parts, the stem of noble dendrobium 16 parts.All the other conditions are identical with embodiment 1.
Embodiment 5:
A kind of moringa seeds health products, comprise moringa seeds, black matrimony vine, the stem of noble dendrobium, probio, the weight of various component: moringa seeds 20 parts, black matrimony vine 22 parts, the stem of noble dendrobium 16 parts, probio 60 parts.All the other conditions are identical with embodiment 1.
Embodiment 6:
A kind of moringa seeds health products, comprise moringa seeds, black matrimony vine, the stem of noble dendrobium, probio, the weight of various component: moringa seeds 40 parts, black matrimony vine 22 parts, the stem of noble dendrobium 6 parts, probio 90 parts.All the other conditions are identical with embodiment 1.
Embodiment 7:
A kind of moringa seeds health products, comprise moringa seeds, black matrimony vine, the stem of noble dendrobium, probio, the weight of various component: moringa seeds 20 parts, black matrimony vine 22 parts, the stem of noble dendrobium 16 parts, probio 60 parts.All the other conditions are identical with embodiment 1.
Embodiment 8:
A kind of moringa seeds health products, comprise moringa seeds, black matrimony vine, the stem of noble dendrobium, probio, the weight of various component: moringa seeds 40 parts, black matrimony vine 22 parts, the stem of noble dendrobium 6 parts, probio 90 parts.All the other conditions are identical with embodiment 1.
Below the Application Example of said composition, when composition be crude drug or solid extract time, first pulverize, cross after 50 mesh sieves and prepare burden again.
Embodiment 9:
The preparation of moringa seeds troche of health products: moringa seeds, black matrimony vine, stem of noble dendrobium composition 80%, starch 5%, cellulose 15% drop into mixing 10-30 minute in mixer, add ethanol as wetting agent, mixing 10-30 minute, mixed material 12-20 mesh sieve is granulated, and puts into drying equipment inner drying, adds 1% dolomol (or in prior art conventional amount used) of dried particles total amount, whole grain, compressing tablet, packaging, namely makes tablet of the present invention.
Embodiment 10:
The preparation of moringa seeds troche of health products: moringa seeds, black matrimony vine, the stem of noble dendrobium, beneficial female bacteria composition 70%, starch 10%, cellulose 20%, following steps are with embodiment 9.
Embodiment 11:
The preparation of moringa seeds health product capsule: the composition 50% of moringa seeds, black matrimony vine, the stem of noble dendrobium, starch 50%, drops into mixing 10-30 minute in mixer, adds ethanol as wetting agent, mixing 5-10 minute, mixed material 12-20 mesh sieve is granulated, and puts into drying equipment inner drying, adds 1% dolomol (or in prior art conventional amount used) of dried particles total amount, whole grain, capsule charge, packaging, namely making content is heavily the capsule of 0.3g.
The additive of above-mentioned health composition is starch, as being preferably one or more combination thing in inulin, xylo-oligosaccharide or cellulose.
Embodiment 12:
The preparation of electuary: moringa seeds, black matrimony vine, stem of noble dendrobium composition 10%, add 80% dextrin, 10% white granulated sugar, (composition and white granulated sugar are pulverized, crossed 80 mesh sieves), drops into mixing 10-30 minute in mixer, adds ethanol as wetting agent, mixing 5-10 minute, mixed material 12-20 mesh sieve is granulated, and puts into drying equipment inner drying, dry with the screening of 10-60 eye mesh screen, pack after removing coarse granule and fine powder, be packaged into every bag of 3g.
Embodiment 13:
The preparation of oral liquid: moringa seeds, black matrimony vine, stem of noble dendrobium composition, add 5 times amount purified water and obtain oral liquid, add the potassium sorbate (or in prior art conventional amount used) of oral liquid measure 0.1%, filtration, packing, sterilizing, packaging, obtain oral liquid of the present invention.
In sum, described health composition can be used for preparing tablet, capsule, electuary, oral liquid.
Embodiment 14:
Experimental conditions is as follows:
(1) moringa seeds health products (embodiment 4) impact on mouse muscle power:
Only choose Male Kunming strain mice 20-24g40, be divided at random 4 groups (often organizing 10 mouse), wherein establish physiological saline negative control group and 3 moringa seeds health products various dose groups of the present invention, little, in, the extract of large three dosage component gavage moringa seeds other every day health products, dosage is respectively 0.5g/kg, 1.0g/kg, 1.5g/kg, successive administration 40d, carries out mouse heavy burden test after last gavage 30min.Mouse tail is born a heavy burden 5%, is placed in 100cm × 80cm × 40cm pond went swimming, depth of water 30cm, water temperature 25 DEG C ± 0.5 DEG C, 10, every pond mouse, record mouse swimming beginning is the mice burden swimming time to the death time.Experiment shows, 1.0g/kg, 1.5g/kg group can obviously extend the mice burden swimming time, compares have conspicuousness (P < 0.01) with negative group.The results are shown in Table 1.
Table 1 physical exertion is tested
| Group | Dosage (g/Kg) | Swimming time (S) |
| Negative control group | Physiological saline | 320.5±126.4 |
| Small dose group | 0.5 | 390.3±174.5 |
| Middle dosage group | 1.0 | 585.7±220.4 |
| Heavy dose of group | 1.5 | 647.0±284.7 |
(2) moringa seeds health products (embodiment 13) impact on small white mouse immunity.Get 615 inbred strais Kunming kind female mice 36.After weighing, get body weight the mouse of 20-24 gram, be divided into 12 groups at random, often organize 3, make weight differences between each group not remarkable.Then being put on 12 positions at random, random extracting 4 groups out as drinking group (I), extract 4 groups afterwards more at random out as injection group (II), remaining 4 groups as a control group (III), environment indifference can be made like this.Drink group mouse and often only drink 1ml moringa seeds health products solution every day, injection group mouse lumbar injection every day 0.1ml moringa seeds health products solution, 4:00 drank to mouse and injected moringa seeds health products solution every afternoon.Experimental period is 30 days.Experimental session, mouse ad lib and drinking-water.
Test after 40 days, start immunity test experiments immediately, mouse peripheral T lymphocyte enzyme labeling decoration method (affecting the experimental technique of cellular immune function), interpretation is as follows, the results are shown in Table 2, after drinking these moringa seeds health products to mouse, the percentage shared by T lymphocyte significantly improves, drink group and the poor heteropole of control group remarkable (P≤0.01), illustrate that oral moringa seeds health products can obviously promote mouse cell immunologic function.Injection group and control group comparing difference also extremely significantly (P≤0.01), illustrate that injection moringa seeds health products also can promote mouse cell immunologic function.
Table 2 moringa seeds health products are on the impact of mouse T lymphocyte percentage composition
| Group | Mouse number (only) | Dosage (ml/ only) | T lymphocyte percentage % (% ± Sd) |
| I | 12 | 1 | 67.914±2.887 |
| II | 12 | 0.1 | 67.138±2.013 |
| III | 12 | 0 | 61.109±2.142 |
Claims (6)
1. moringa seeds health products, is characterized in that, are mainly grouped into by the one-tenth of following weight portion: moringa seeds 20-60 part, black matrimony vine 5-25 part, stem of noble dendrobium 2-20 part are obtained by mixing.
2. a kind of moringa seeds health products according to claim 1, is characterized in that, are be grouped into by the one-tenth of following weight portion: moringa seeds 30-50 part, black matrimony vine 8-22 part, stem of noble dendrobium 5-16 part are obtained by mixing.
3. a kind of moringa seeds health products according to claim 1, is characterized in that, also comprise probio, account for 60-90 part by weight.
4. a kind of moringa seeds health products according to claim 1, is characterized in that, also comprise probio, account for 70-80 part by weight.
5. a kind of moringa seeds health products according to claim 1 or 3, is characterized in that, also comprise inulin, starch, xylo-oligosaccharide or cellulose.
6. according to claim 1 or 2 or 3 or 4 a kind of moringa seeds health products, it is characterized in that: described compound may be used for preparing electuary, capsule, oral liquid or tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510435212.7A CN105054007A (en) | 2015-07-23 | 2015-07-23 | Health-care moringa seed product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510435212.7A CN105054007A (en) | 2015-07-23 | 2015-07-23 | Health-care moringa seed product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105054007A true CN105054007A (en) | 2015-11-18 |
Family
ID=54483730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510435212.7A Pending CN105054007A (en) | 2015-07-23 | 2015-07-23 | Health-care moringa seed product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105054007A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105326046A (en) * | 2015-12-02 | 2016-02-17 | 云南宁泽生物科技有限公司 | Moringa gaoke tablets and preparation method thereof |
| CN105380267A (en) * | 2015-11-24 | 2016-03-09 | 云南沃淳农业科技有限公司 | Functional food and preparation method thereof |
| CN106047593A (en) * | 2016-05-26 | 2016-10-26 | 靳登山 | Moringa-seed health-care rice wine |
| CN106666705A (en) * | 2016-11-16 | 2017-05-17 | 中科智慧保健品有限公司 | Health oral liquid |
| CN108771074A (en) * | 2018-05-17 | 2018-11-09 | 广西柳州市桑辰科技有限公司 | A kind of production method of moringa seeds solid beverage |
| CN109198620A (en) * | 2018-09-27 | 2019-01-15 | 云南农业大学 | Moringa seeds compound nutritional plain piece and preparation method thereof |
-
2015
- 2015-07-23 CN CN201510435212.7A patent/CN105054007A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105380267A (en) * | 2015-11-24 | 2016-03-09 | 云南沃淳农业科技有限公司 | Functional food and preparation method thereof |
| CN105380267B (en) * | 2015-11-24 | 2018-11-06 | 云南沃淳农业科技有限公司 | A kind of functional food and preparation method thereof |
| CN105326046A (en) * | 2015-12-02 | 2016-02-17 | 云南宁泽生物科技有限公司 | Moringa gaoke tablets and preparation method thereof |
| CN106047593A (en) * | 2016-05-26 | 2016-10-26 | 靳登山 | Moringa-seed health-care rice wine |
| CN106666705A (en) * | 2016-11-16 | 2017-05-17 | 中科智慧保健品有限公司 | Health oral liquid |
| CN108771074A (en) * | 2018-05-17 | 2018-11-09 | 广西柳州市桑辰科技有限公司 | A kind of production method of moringa seeds solid beverage |
| CN108771074B (en) * | 2018-05-17 | 2021-08-31 | 广西贺州市桑辰科技有限公司 | Preparation method of moringa seed solid beverage |
| CN109198620A (en) * | 2018-09-27 | 2019-01-15 | 云南农业大学 | Moringa seeds compound nutritional plain piece and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105054007A (en) | Health-care moringa seed product | |
| US12256764B2 (en) | Healthful supplement food | |
| CN105029440A (en) | Maca health care food and making method | |
| CN104137952A (en) | Nutrient food for maintaining heart health of dogs and cats and preparation method of nutrient food | |
| CN103875903A (en) | Pig feed in suckling period as well as preparation method thereof | |
| CN108634201A (en) | Clearing damp invigorating the spleen meal replacement powder | |
| CN104435257A (en) | Composition conducive to lowering of cholesterol, and preparation method, preparation and application of composition | |
| CN105558638A (en) | Rosa roxbunghii beverage preparation method | |
| CN105168566A (en) | Health care composition | |
| CN105028925A (en) | Chinese herbal medicine feed nutrient for poultry | |
| CN104957474A (en) | Moringa oleifera composition for reducing blood pressure and preparation method of moringa oleifera composition | |
| CN105168567A (en) | Maca health care composition | |
| CN105168953A (en) | Maca multifunctional health care product | |
| CN105168564A (en) | Moringa seed health care composition | |
| CN105998938A (en) | Feed additive for treating bacterial red skin disease of tilapia mossambica and preparation method therefor | |
| CN105029413A (en) | Maca health care composition | |
| CN103932172A (en) | Cordyceps health-care product and preparation method thereof | |
| CN105168952A (en) | Compound maca health care product | |
| CN103283968A (en) | Chinese herbal medicine feed for bionic raising of animals | |
| CN102302104A (en) | Lycopene bee pollen and making method thereof | |
| CN102224926A (en) | Mung bean porridge for treating epistaxis and preventing cerebrovascular rupture | |
| CN105168951A (en) | Health care composition | |
| CN1895328B (en) | Use of persimmon-plant material in preparation of oxygen-tolerent and anti-fatigue composition | |
| CN105168954A (en) | Health care composition | |
| CN103190613A (en) | Preparation method of purple sweet potato health product composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151118 |